[HTML][HTML] Respiratory pathophysiology of mechanically ventilated patients with COVID-19: a cohort study
…, A Moskowitz, BD Medoff, KA Hibbert… - American journal of …, 2020 - atsjournals.org
Methods Population and setting. We studied all adult inpatients with SARS-CoV-2 infection
and respiratory failure managed with invasive mechanical ventilation at Massachusetts …
and respiratory failure managed with invasive mechanical ventilation at Massachusetts …
Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a …
…, E Almasri, M Fayed, MR Filbin, KA Hibbert… - The Lancet Infectious …, 2022 - thelancet.com
Background We aimed to assess the efficacy and safety of two neutralising monoclonal
antibody therapies (sotrovimab [Vir Biotechnology and GlaxoSmithKline] and BRII-196 plus BRII-…
antibody therapies (sotrovimab [Vir Biotechnology and GlaxoSmithKline] and BRII-196 plus BRII-…
Lung histopathology in coronavirus disease 2019 as compared with severe acute respiratory sydrome and H1N1 influenza: a systematic review
…, CR Petri, TF Calhoun, LN Brenner, KA Hibbert… - Chest, 2021 - Elsevier
Background Patients with severe coronavirus disease 2019 (COVID-19) have respiratory
failure with hypoxemia and acute bilateral pulmonary infiltrates, consistent with ARDS. …
failure with hypoxemia and acute bilateral pulmonary infiltrates, consistent with ARDS. …
Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: A randomised, double-blind, phase 3 trial
…, F Shehadeh, MR Filbin, KA Hibbert… - The Lancet …, 2022 - thelancet.com
Background Tixagevimab–cilgavimab is a neutralising monoclonal antibody combination
hypothesised to improve outcomes for patients hospitalised with COVID-19. We aimed to …
hypothesised to improve outcomes for patients hospitalised with COVID-19. We aimed to …
Assessment of symptom, disability, and financial trajectories in patients hospitalized for COVID-19 at 6 months
…, GW Hendey, CM Hendrickson, KA Hibbert… - JAMA network …, 2023 - jamanetwork.com
Importance Individuals who survived COVID-19 often report persistent symptoms, disabilities,
and financial consequences. However, national longitudinal estimates of symptom burden …
and financial consequences. However, national longitudinal estimates of symptom burden …
[HTML][HTML] Recent advances in the understanding and management of ARDS
TJ Peck, KA Hibbert - F1000Research, 2019 - ncbi.nlm.nih.gov
The acute respiratory distress syndrome (ARDS) remains a common and highly morbid
condition despite advances in the understanding and management of this complex critical illness…
condition despite advances in the understanding and management of this complex critical illness…
[HTML][HTML] Exercise performance in patients with post-acute sequelae of SARS-CoV-2 infection compared to patients with unexplained dyspnea
…, LP Hariri, RS Knipe, BD Medoff, KA Hibbert… - …, 2021 - thelancet.com
Background Dyspnea and exercise intolerance are commonly reported post-acute
sequelae of SARS-CoV-2 infection (PASC), but routine diagnostic testing is often normal. …
sequelae of SARS-CoV-2 infection (PASC), but routine diagnostic testing is often normal. …
Risk factors and outcomes associated with new-onset atrial fibrillation during acute respiratory distress syndrome
DB Ambrus, EJ Benjamin, EK Bajwa, KA Hibbert… - Journal of critical …, 2015 - Elsevier
Purpose Outcomes and risk factors associated with new-onset atrial fibrillation (AF) during
acute respiratory distress syndrome (ARDS) are unclear. We investigated mortality and risk …
acute respiratory distress syndrome (ARDS) are unclear. We investigated mortality and risk …
Development and prospective validation of a deep learning algorithm for predicting need for mechanical ventilation
…, G Wardi, P Paul, M Carlile, LN Brenner, KA Hibbert… - Chest, 2021 - Elsevier
Background Objective and early identification of hospitalized patients, and particularly those
with novel coronavirus disease 2019 (COVID-19), who may require mechanical ventilation (…
with novel coronavirus disease 2019 (COVID-19), who may require mechanical ventilation (…
Veno-venous extracorporeal membrane oxygenation for respiratory failure in COVID-19 patients: early experience from a major academic medical center in North …
AA Osho, P Moonsamy, KA Hibbert, KT Shelton… - Annals of …, 2020 - journals.lww.com
Methods: As a major regional referral program, we used the framework of our well-established
ECMO service-line to outline specific team structures, modified patient eligibility criteria, …
ECMO service-line to outline specific team structures, modified patient eligibility criteria, …